A detailed history of Washington Trust CO transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Washington Trust CO holds 1,500 shares of FHTX stock, worth $12,105. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,500
Previous 1,500 -0.0%
Holding current value
$12,105
Previous $8,000 62.5%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

BUY
$4.66 - $8.99 $6,980 - $13,467
1,498 Added 74900.0%
1,500 $9,000
Q1 2023

May 04, 2023

SELL
$4.66 - $8.99 $6,980 - $13,467
-1,498 Reduced 99.87%
2 $9,000
Q4 2021

Feb 09, 2022

BUY
$10.79 - $22.87 $16,184 - $34,305
1,500 New
1,500 $34,000

Others Institutions Holding FHTX

About Foghorn Therapeutics Inc.


  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $336M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Washington Trust CO Portfolio

Follow Washington Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.